A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19

NCT04362059 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Infections

Interventions

DEVICE: COVSurf Drug Delivery System
OTHER: Standard of Care

Sponsor

University Hospital Southampton NHS Foundation Trust

Collaborators

[object Object]
[object Object]